Lilly pricing policy
Executive Summary
Company announces April 1 that "the weighted average price increases of its total pharmaceutical product portfolio will not exceed the projected rate of inflation for 1993." Furthermore, Lilly says that during 1993 the company "will not raise the list price of any single pharmaceutical product at a rate greater than 2% above the anticipated Consumer Price Index".